Eye-tracking Technology for Severe Communication Disability

March 30, 2023 updated by: Francesca Cucinotta, IRCCS Centro Neurolesi "Bonino-Pulejo"

Augmentative Alternative Communication Intervention Delivered Via Eye-tracking Technology

The aim of this project is to develop an Augmentative and Alternative Communication intervention through the use of Eye tracker system.

Study Overview

Status

Recruiting

Detailed Description

The term "complex communication needs" includes all patients who present severe disturbances in speech and language production and/or in comprehension, in relation to oral or written communication modalities. The main purpose of Augmentative and Alternative Communication (AAC) is to promote the best possible communication for people with complex communication needs, through the use of techniques, methods and tools aimed not at replacing pre-existing communication methods but at increasing skills of natural communication through the enhancement of present skills. The Eye tracker system, thanks to allows the recording and analysis of eye movements, could be used successfully to support communication in patients with severe communication disability.

The goal of this study is to develop an efficacy Augmentative and Alternative Communication intervention using eye-tracking technology for patients with severe communication disability.

The secondary objective was to examine the psychosocial impact of technology for AAC on parents' perspectives and quality of life.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • aged between 3 and 17 years affected by neuropsychiatric pathology presenting complex communication needs
  • Control of eye motility and visual fixation
  • ability to maintain position in front of the monitor
  • availability of at least one member of the family nucleus to participate in the therapeutic process
  • cognitive skills appropriate to the task such as being able to recognize images and being able to memorize procedures necessary to use the various basic functions

Exclusion Criteria:

  • age not between 3 and 17 years
  • difficulty in controlling ocular motility and visual fixation
  • the unavailability of at least one member of the family nucleus to participate in the therapeutic process
  • impaired cognitive skills on the task such as being able to recognize pictures and being able to memorize procedures necessary to use various basic functions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group (EG)
The experimental group will undergo treatment with innovative high-tech tools, such as Eye Tracking, for communication purposes. The duration of the treatment will be six months, twice a week, with sessions of 45 minutes.
The AAC treatment will be supported by the use of an innovative high-tech tool, such as Eye Tracking. The duration of treatment will be 6 months, with sessions of 45 minutes twice a week.
Active Comparator: Control Group (CG)

The control group will undergo conventional AAC treatment, with low-tech tools, such as PECS or sign language.

The duration of the treatment will be six months, twice a week, with sessions of 45 minutes.

Treatment involves the use of conventional AAC, with low-tech tools, such as PECS or sign language. The duration of treatment will be six months, twice a week, with sessions of 45 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MacArthur-Bates Communicative Development Inventory
Time Frame: Month 0
The MacArthur-Bates Communicative Development Inventory is a questionnaire for parents. This is used for the study and evaluation of communication and language in children with typical and atypical development.
Month 0
MacArthur-Bates Communicative Development Inventory
Time Frame: Month 3
The MacArthur-Bates Communicative Development Inventory is a questionnaire for parents. This is used for the study and evaluation of communication and language in children with typical and atypical development.
Month 3
MacArthur-Bates Communicative Development Inventory
Time Frame: Month 6
The MacArthur-Bates Communicative Development Inventory is a questionnaire for parents. This is used for the study and evaluation of communication and language in children with typical and atypical development.
Month 6
Communication Matrix
Time Frame: Month 0
is an online assessment tool created to help professionals and family members support people with severe communication disorders on their journey to greater self-expression. Total score on an assessment of early expressive communication skills.
Month 0
Communication Matrix
Time Frame: Month 3
is an online assessment tool created to help professionals and family members support people with severe communication disorders on their journey to greater self-expression. Total score on an assessment of early expressive communication skills.
Month 3
Communication Matrix
Time Frame: Month 6
is an online assessment tool created to help professionals and family members support people with severe communication disorders on their journey to greater self-expression. Total score on an assessment of early expressive communication skills.
Month 6
Interactive Check list for Augmentative Communication
Time Frame: Month 0
Interactive Check list for Augmentative Communication is an observational tool for evaluating interactive behavior
Month 0
Interactive Check list for Augmentative Communication
Time Frame: Month 3
Interactive Check list for Augmentative Communication is an observational tool for evaluating interactive behavior
Month 3
Interactive Check list for Augmentative Communication
Time Frame: Month 6
Interactive Check list for Augmentative Communication is an observational tool for evaluating interactive behavior
Month 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The World Health Organization Quality of Life
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
The World Health Organization Quality of Life -BREF consists of 26 questions. The World Health Organization Quality of Life -BREF has Likert-type scoring ranging from 1 to 5. As the score obtained from the sub-domains of the scale increases, the quality of life increases.
T0 (Baseline) - T1 (3 months) - T2 (6 months)
Parenting Stress Index
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
Measures parenting stress
T0 (Baseline) - T1 (3 months) - T2 (6 months)
Forerunners in Communication - ComFor
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
Forerunners in Communication assesses the precursors of augmentative communication. It measures the ability to perceive and attribute meanings to forms of communication
T0 (Baseline) - T1 (3 months) - T2 (6 months)
Vineland Adaptive Behavior Scales II
Time Frame: T0 (Baseline) - T1 (3 months) - T2 (6 months)
The Vineland Adaptive Behavior Scales are a standardized semi-structured interview to measure adaptive behavior, among the most sensitive to change in autism research. Standard scores have a mean of 100 and a standard deviation of 15.
T0 (Baseline) - T1 (3 months) - T2 (6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2022

Primary Completion (Anticipated)

December 31, 2026

Study Completion (Anticipated)

December 31, 2026

Study Registration Dates

First Submitted

March 17, 2023

First Submitted That Met QC Criteria

March 30, 2023

First Posted (Actual)

April 11, 2023

Study Record Updates

Last Update Posted (Actual)

April 11, 2023

Last Update Submitted That Met QC Criteria

March 30, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Communication Disabilities

Clinical Trials on AAC + Eye Tracking

Subscribe